IA
FOLD

IndexIQ Advisors’s Amicus Therapeutics FOLD Stock Holding History

IndexIQ Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-22,667
Closed -$523K – 1197
2020
Q4 		$523K Buy
22,667
+2,340
+12% +$47.9K 0.02% 368
2020
Q3 		$287K Buy
20,327
+1,103
+6% +$16.1K 0.01% 432
2020
Q2 		$290K Sell
19,224
-43
-0.2% -$524 0.01% 342
2020
Q1 		$178K Buy
+19,267
New +$183K 0.01% 681

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IndexIQ Advisors's FOLD Position: Q1 2021 in Review

IndexIQ Advisors sold out of Amicus Therapeutics (FOLD) in Q1 2021, closing a stake of 22,667 shares — an estimated $523K sold.

IndexIQ Advisors first reported a position in FOLD in Q1 2020 and held it in 4 quarters. The position peaked at $523K in Q4 2020. 259 funds tracked by Wall St. Rank hold FOLD as of Q1 2021.

  • IndexIQ Advisors reported no remaining Amicus Therapeutics position as of Q1 2021 after selling out during the quarter.
  • IndexIQ Advisors sold 22,667 Amicus Therapeutics shares in Q1 2021, an estimated $523K.
  • IndexIQ Advisors first reported a position in Amicus Therapeutics in Q1 2020 and held it in 4 quarters.
  • IndexIQ Advisors's Amicus Therapeutics position peaked at $523K in Q4 2020.
  • 259 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2021.

Based on IndexIQ Advisors's 13F filing for Q1 2021, filed 7 May 2021.